Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI
BMS is moving beyond conversational AI into what it describes as “agentic” systems
BMS is moving beyond conversational AI into what it describes as “agentic” systems
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
The new facility at Byatarayanapura introduces Karnataka’s first Elekta Unity MR-Linac technology
The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Next-generation berberine formulation developed with BioSOLVE Technology targets metabolic health, blood sugar balance, and weight management
Subscribe To Our Newsletter & Stay Updated